Division of Infectious Disease, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.
Am J Transplant. 2021 Aug;21(8):2885-2889. doi: 10.1111/ajt.16532. Epub 2021 Mar 15.
We describe a case of proven transmission of SARS-CoV-2 from lung donor to recipient. The donor had no clinical history or findings suggestive of infection with SARS-CoV-2 and tested negative by reverse transcriptase polymerase chain reaction (RT-PCR) on a nasopharyngeal (NP) swab obtained within 48 h of procurement. Lower respiratory tract testing was not performed. The recipient developed fever, hypotension, and pulmonary infiltrates on posttransplant day (PTD) 3, and RT-PCR testing for SARS-CoV-2 on an NP swab specimen was non-reactive, but positive on bronchoalveolar lavage (BAL) fluid. One thoracic surgeon present during the transplantation procedure developed COVID-19. Sequence analysis of isolates from donor BAL fluid (obtained at procurement), the recipient, and the infected thoracic surgeon proved donor origin of recipient and health-care worker (HCW) infection. No other organs were procured from this donor. Transplant centers and organ procurement organizations should perform SARS-CoV-2 testing of lower respiratory tract specimens from potential lung donors, and consider enhanced personal protective equipment for HCWs involved in lung procurement and transplantation.
我们描述了一例经证实的 SARS-CoV-2 从肺供体到受体的传播。供体无临床病史或提示 SARS-CoV-2 感染的发现,在获取后 48 小时内通过鼻咽(NP)拭子进行的逆转录酶聚合酶链反应(RT-PCR)检测结果为阴性。未进行下呼吸道检测。受体在移植后天 3 天出现发热、低血压和肺部浸润,NP 拭子标本的 SARS-CoV-2 RT-PCR 检测结果为阴性,但支气管肺泡灌洗液(BAL)为阳性。在移植过程中一位胸外科医生出现 COVID-19。对供体 BAL 液(在获取时获得)、受体和受感染的胸外科医生的分离物进行的序列分析证明了供体和医护人员(HCW)感染的来源。该供体未获取其他器官。移植中心和器官获取组织应针对潜在肺供体的下呼吸道标本进行 SARS-CoV-2 检测,并考虑为参与肺获取和移植的 HCW 提供增强的个人防护设备。